Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies?
Tyler
Kenneth L
KL
D006801:Humans; D056747:Immunomodulation; D007577:JC Virus / Q000472:pathogenicity; D007968:Leukoencephalopathy, Progressive Multifocal / Q000276:immunology* / Q000517:prevention & control*